Hui Wang

Hui Wang

Director/Board Member bei VIVA BIOTECH HOLDINGS

Vermögen: 30 Mio $ am 30.04.2024

52 Jahre
Health Technology
Finance
Consumer Services

Profil

Hui Wang has founded Jiangsu Highlight Equity Investment Management Co. Ltd.
in 2014, where he holds the title of Founding Partner.
He is currently the Chief Executive Officer at Highlight Capital Fund since 2014.
Mr. Wang is also a Director at Suzhou Kintor Pharmaceuticals, Inc., a Non-Executive Director at Viva Biotech Holdings starting in 2024, a Director at Biotheus, Inc., a Non-Executive Director at Zylox-Tonbridge Medical Technology Co., Ltd.
since 2020, and a Director at WinnTi Medical Technology (Shanghai) Co., Ltd.
Mr. Wang previously served as a Senior Partner at CDH Venture Partners LP starting in 2009.
He held the position of Vice Chairman at Juva (Tianjin) Medical Technology Co., Ltd.
and Chairman-Supervisory Board at Chengdu Angel Healthcare Holding Co., Ltd.
Mr. Wang was also a Non-Executive Director at Zylox-Tonbridge Medical Technology Co., Ltd.
from 2015 to 2018 and a General Partner at CDH Investments from 2009 to 2014.
He has also worked as a Principal at Becton, Dickinson & Co. Mr. Wang received a graduate degree from New York University in 1998, an undergraduate degree from the University of Science & Technology of China in 1996, and an MBA from London Business School in 2007.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
29.04.2024 22 180 948 ( 6,83% ) 30 Mio $ 30.04.2024

Aktive Positionen von Hui Wang

UnternehmenPositionBeginn
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. Director/Board Member 28.12.2020
VIVA BIOTECH HOLDINGS Director/Board Member 18.01.2024
Director/Board Member -
Director/Board Member -
Corporate Officer/Principal 01.01.2009
Founder 01.01.2014
Chief Executive Officer 01.01.2014
Director/Board Member -
Alle aktiven Positionen von Hui Wang

Ehemalige bekannte Positionen von Hui Wang

UnternehmenPositionEnde
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. Director/Board Member 01.03.2018
░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░ ░░░░ ░░░░░░░░ -
Sehen Sie sich die Erfahrung von Hui Wang im Detail an

Ausbildung von Hui Wang

New York University Graduate Degree
University of Science & Technology of China Undergraduate Degree
London Business School Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Hui Wang im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

15

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
BECTON, DICKINSON AND COMPANY

Health Technology

VIVA BIOTECH HOLDINGS

Health Technology

ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Health Technology

Private Unternehmen9

Finance

Finance

Finance

Finance

Finance

Distribution Services

Health Technology

Health Technology

Health Technology

Sehen Sie sich die Unternehmensverbindungen an